Triazure and public drug policies.
D001380:Azauridine / Q000009:adverse effects / Q000031:analogs & derivatives* / Q000627:therapeutic use*; D007880:Legislation, Drug; D011565:Psoriasis / Q000188:drug therapy*; D012306:Risk; D014481:United States; D014486:United States Food and Drug Administration
D001380:Azauridine